Jeremy Lim
Algemeen Directeur bij AMILI Pte Ltd.
Profiel
Jeremy Lim founded AMILI Pte Ltd., where he worked as Chief Executive Officer.
Dr. Lim also currently works at HEAL Partners, as Advisor.
Dr. Lim received his graduate degree in 2003 from The Johns Hopkins University.
Actieve functies van Jeremy Lim
Bedrijven | Functie | Begin |
---|---|---|
AMILI Pte Ltd.
AMILI Pte Ltd. BiotechnologyHealth Technology AMILI Pte Ltd. is the world's largest multi-ethnic gut microbiota database and Southeast's first and only faecal microbiota transplant (FMT) bank. The company is based in Singapore, Singapore. The clinical research of the Singaporean company is focused on health and wellness, oncology, and response to microbiome-based therapeutics. AMILI offers a full suite of gut microbiome related services, ranging from study design, sample collection, processing, microbiome sequencing, and subsequent bioinformatics analysis. AMILI aims to advance microbiome research and apply this knowledge to improve human health. FMT preparations can be delivered via capsules, colonoscopies, nasoenteric tubes, and enemas. While AMILI currently only offers FMT preparations to be administered via colonoscopy, FMT preparations for alternative administration routes are in the pipeline. The company was founded by Jeremy Lim, who has been the CEO since incorporation. | Algemeen Directeur | - |
HEAL Partners
HEAL Partners Investment ManagersFinance HEAL Partners (HEAL Partners) is a venture capital firm founded in 2020. The firm is headquartered in Australia. | Consultant / Adviseur | - |
Opleiding van Jeremy Lim
The Johns Hopkins University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
HEAL Partners
HEAL Partners Investment ManagersFinance HEAL Partners (HEAL Partners) is a venture capital firm founded in 2020. The firm is headquartered in Australia. | Finance |
AMILI Pte Ltd.
AMILI Pte Ltd. BiotechnologyHealth Technology AMILI Pte Ltd. is the world's largest multi-ethnic gut microbiota database and Southeast's first and only faecal microbiota transplant (FMT) bank. The company is based in Singapore, Singapore. The clinical research of the Singaporean company is focused on health and wellness, oncology, and response to microbiome-based therapeutics. AMILI offers a full suite of gut microbiome related services, ranging from study design, sample collection, processing, microbiome sequencing, and subsequent bioinformatics analysis. AMILI aims to advance microbiome research and apply this knowledge to improve human health. FMT preparations can be delivered via capsules, colonoscopies, nasoenteric tubes, and enemas. While AMILI currently only offers FMT preparations to be administered via colonoscopy, FMT preparations for alternative administration routes are in the pipeline. The company was founded by Jeremy Lim, who has been the CEO since incorporation. | Health Technology |